1. Home
  2. MLTX vs LE Comparison

MLTX vs LE Comparison

Compare MLTX & LE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • LE
  • Stock Information
  • Founded
  • MLTX 2021
  • LE 1963
  • Country
  • MLTX Switzerland
  • LE United States
  • Employees
  • MLTX N/A
  • LE N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • LE Clothing/Shoe/Accessory Stores
  • Sector
  • MLTX Health Care
  • LE Consumer Discretionary
  • Exchange
  • MLTX Nasdaq
  • LE Nasdaq
  • Market Cap
  • MLTX 535.3M
  • LE 440.9M
  • IPO Year
  • MLTX N/A
  • LE N/A
  • Fundamental
  • Price
  • MLTX $9.40
  • LE $15.06
  • Analyst Decision
  • MLTX Buy
  • LE Strong Buy
  • Analyst Count
  • MLTX 9
  • LE 2
  • Target Price
  • MLTX $37.63
  • LE $20.00
  • AVG Volume (30 Days)
  • MLTX 9.7M
  • LE 329.1K
  • Earning Date
  • MLTX 11-06-2025
  • LE 09-09-2025
  • Dividend Yield
  • MLTX N/A
  • LE N/A
  • EPS Growth
  • MLTX N/A
  • LE N/A
  • EPS
  • MLTX N/A
  • LE 0.19
  • Revenue
  • MLTX N/A
  • LE $1,315,578,000.00
  • Revenue This Year
  • MLTX N/A
  • LE $3.01
  • Revenue Next Year
  • MLTX N/A
  • LE $2.35
  • P/E Ratio
  • MLTX N/A
  • LE $78.93
  • Revenue Growth
  • MLTX N/A
  • LE N/A
  • 52 Week Low
  • MLTX $5.95
  • LE $7.65
  • 52 Week High
  • MLTX $62.75
  • LE $19.88
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 23.29
  • LE 53.45
  • Support Level
  • MLTX $6.56
  • LE $13.78
  • Resistance Level
  • MLTX $7.48
  • LE $15.63
  • Average True Range (ATR)
  • MLTX 2.22
  • LE 0.63
  • MACD
  • MLTX -4.37
  • LE -0.07
  • Stochastic Oscillator
  • MLTX 6.07
  • LE 51.92

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About LE Lands' End Inc.

Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically operates in USA, Europe, Asia, it derives a majority of its revenue from the United States.

Share on Social Networks: